Gene · 6304
Papers1,882
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,882
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of retraction: MicroRNA-409 regulates the proliferation and invasion of breast cancer cell lines by targeting special AT-rich sequence-binding protein 1 (SATB1). | Bioengineered | 2026 | 42821799 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis identifies programmed cell death-related biomarkers and their environmentally relevant toxicological interactions in abdominal aortic aneurysm. | Ecotoxicol Environ Saf | 2026 | 42810262 | PubTator, text mining | PubMed |
| Editorial Expression of Concern: SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation. | Dig Dis Sci | 2026 | 42663897 | PubTator, text mining | PubMed |
| Targeting the fate of exhausted CD8+ T cells. | Trends Immunol | 2026 | 42538164 | PubTator, text mining | PubMed |
| CDState Resolves Malignant Cell Heterogeneity from Bulk Tumor RNA Sequencing Data. | Cancer Res | 2026 | 42531606 | PubTator, text mining | PubMed |
SATB1 regulates the osteogenic differentiation of PDLSCs via HDAC1 mediated non-histone protein deacetylation and ubiquitination mechanism and through p38 MAPK pathway under hydrogen peroxide-induced senescent conditions. | Stem Cell Res Ther | 2026 | 42387594 | PubTator, text mining | PubMed |
| SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells. | EMBO Rep | 2026 | 42286212 | PubTator, text mining | PubMed |
| Genome Organizer SATB1 selectively activates a defined subset of EMT genes driving metastatic breast cancer. | bioRxiv | 2026 | 42282767 | PubTator, text mining | PubMed |
| Integrated environmental and genomic analysis reveals the drivers and genetic mechanisms of agro-climatic adaptation in geese. | BMC Genomics | 2026 | 42218382 | PubTator, text mining | PubMed |
| Satb1 enforces CD4+ effector T cell lineage stability by repressing Foxp3 via DNA methylation. | Biochem Biophys Res Commun | 2026 | 42202530 | PubTator, text mining | PubMed |
| Identification and Functional Characterization of a Novel De Novo SATB1 Frameshift Variant in a Patient with Epilepsy-Dominant Neurodevelopmental Disorders. | Genes (Basel) | 2026 | 42195022 | PubTator, text mining | PubMed |
| Integrated transcriptomic network analysis reveals shared immunogenomic regulators between glioma and type 2 diabetes, highlighting VCAN as a prominent marker. | Sci Rep | 2026 | 42185528 | PubTator, text mining | PubMed |
| Plasma proteome-wide Mendelian randomization reveals multi-ancestry drug targets for gastric cancer. | Front Oncol | 2026 | 42147228 | PubTator, text mining | PubMed |
| SPOP-mediated K27-linked non-degradative ubiquitination of KCNN3 suppressing HCC progression via the CTCF-SATB1 axis. | Cell Death Dis | 2026 | 42106340 | PubTator, text mining | PubMed |
| SATB1 is a targetable modulator of JAK-STAT signaling and cytokines in human Treg and Tconv cells. | bioRxiv | 2026 | 42051317 | PubTator, text mining | PubMed |
| Distinct Inflammatory Programming of Thoracic Cavity White Adipose Immune Cells Regulates Influenza Pathogenesis. | J Infect Dis | 2026 | 41947764 | PubTator, text mining | PubMed |
| Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies. | Sci Adv | 2026 | 41920990 | PubTator, text mining | PubMed |
| Mutant KRAS Heterogeneity Shapes Nuclear Architecture During Pancreatic Cancer Initiation. | Epigenomes | 2026 | 41892368 | PubTator, text mining | PubMed |
| p63 in skin homeostasis and disease: molecular mechanisms and therapeutic potentials. | Cell Death Discov | 2026 | 41876478 | PubTator, text mining | PubMed |
| Ex vivo and in vivo CRISPR/Cas9 screenings identify the roles of protein N-glycosylation in regulating T-cell activation and functions. | Elife | 2026 | 41860948 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6304/papers